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Introduction {#sec0005}
============

Keeping pets is associated with physical and emotional benefits due to its positive effect on people\'s life quality; however, it may present a risk to public health.[@bib0255], [@bib0260] This is because the relationship between men and animals enables transmission of several diseases through pathogens' ability to colonize several hosts.[@bib0265] Therefore, pet birds such as cockatiels may harbor and transmit zoonotic agents through close contact with their owners.[@bib0255], [@bib0270], [@bib0275]

Salmonellosis, a disease caused by bacteria of the *Salmonella* genus, has great relevance due to its lethality and zoonotic potential.[@bib0280] Infected domestic chickens are considered the most common source of human salmonellosis; contaminated chicken meat and eggs are one of the main causes of food poisoning worldwide.[@bib0280] Furthermore, wild and exotic avian species are also considered *Salmonella* reservoirs.[@bib0285]

*Escherichia coli* is a commensal bacterium of the intestinal microbiome of homeothermic animals. However, pathogenic strains are capable of causing intestinal and extraintestinal diseases in humans, and mammal and avian species, leading to serious economic losses and public health issues.[@bib0255], [@bib0275], [@bib0290]

Aside from the zoonotic potential of these enterobacteriaceae, concerns regarding antimicrobial resistance are currently on the rise.[@bib0290], [@bib0295] Broad use of antimicrobial drugs, either to treat diseases or in livestock production, resulted in selective pressure and the consequent appearance of multiresistant bacterial strains.[@bib0300]

Antimicrobial resistant enterobacteria may be transmitted to humans through animal contact, contaminated food or the environment.[@bib0275], [@bib0300] After colonizing new hosts, they may transfer resistance genes to microorganisms of the local microbiota. Antimicrobial resistance genes may then recombine among these strains, creating new ones resistant to several drugs.[@bib0275], [@bib0300]

Despite the great global concern with microbial resistances, there is little information available on the epidemiological role of pet birds in the epidemiology of *E. coli* and *Salmonella* spp.[@bib0280] Recent studies in Brazil showed that free-ranging wild birds may harbor potentially pathogenic and antimicrobial resistant strains.[@bib0305]

The aim of this study was to survey cloacal samples of captive cockatiels (*Nymphicus hollandicus*) for potentially pathogenic *Salmonella* spp. and *E. coli.* We also evaluated the antimicrobial resistance profile of the isolates, as well as resistance genes belonging to the main antimicrobial classes.

Materials and methods {#sec0010}
=====================

All animal procedures followed ethical principles and were approved by the Ethical Committee in Animal Use (237/14 CEUA/UNIP).

We collected samples from 94 clinically healthy male and female cockatiels (*N. hollandicus*) kept in captivity: 8 from a pet shop, 28 from different private residencies and 58 from commercial breeders located in the cities of São Paulo and Niterói, in the States of São Paulo and Rio de Janeiro (Brazil), respectively.

Upon physical restraining and after pericloacal asepsis with 70% alcoholic solution, two uretral swabs were rubbed against the cloacal mucosa, kept in refrigerated Stuart media and processed within 48 h.

Cloacal swab samples for *E. coli* screening were seeded in MacConkey agar (Difco™, Maryland, EUA) and identified following routine biochemical identification,[@bib0310] including EPM, MILi and citrate (Probac™, São Paulo, SP, Brazil) identification kits. Three different *E. coli* isolates from each animal were stored for the remaining tests.

Swabs for *Salmonella* testing followed the protocol suggested by Michael et al., 2003.[@bib0315] The swabs were cultivated in buffered peptone water at 37 °C by 24 h. Aliquots of 1 ml were subcultured in 9 ml of tetrathionate Müller--Kauffmann (TMK, Difco™, Maryland, EUA). After 24 h of incubation, aliquots of the selective broths were streaked onto xylose-lysine-tergitol 4 agar (XLT4, Difco™, Maryland, EUA). After 24 h of incubation (37 °C), typical colonies of *Salmonella* were isolated and subjected to biochemical identification.[@bib0315]

We performed polymerase chain reaction (PCR) on the *E. coli* isolates in search of extraintestinal pathogenic strains (ExPEC) characteristic genes by accessing genes *papC*,[@bib0320] *papEF*,[@bib0325] *sfa*,[@bib0320] *fyuA*,[@bib0330] *cnf1*,[@bib0325] *hlyA*,[@bib0325] *cvaC*,[@bib0330] and *malX*,[@bib0330] aside from five avian virulence predicting genes: *ironN*,[@bib0335] *ompT*,[@bib0335] *hlyF*,[@bib0335] *iss*,[@bib0335] and *iutA.*[@bib0335] The following diarrheagenic-related genes were also studied: *stx1*,[@bib0340] *stx*2,[@bib0340] ST,[@bib0345] LT,[@bib0345] *astA*,[@bib0350] *ipaH*,[@bib0355] *agg*R,[@bib0360] *eae*[@bib0365], and *bfpA.*[@bib0370] All *E. coli* isolates were submitted to the Fundação Oswaldo Cruz (FIOCRUZ-RJ), a reference laboratory, to be tested with O157 and H7 antisera.

Drug sensitivity was evaluated by diffusing plates, following international established standards.[@bib0375], [@bib0380] The used drugs (Cefar™, São Paulo, SP, Brazil) belong to the following antimicrobial categories: β-lactams -- penicillin (amoxicillin -- AMO and ampicillin -- AMP), β-lactams -- cephalosporins (cephalexin -- CFE, cefoxitin -- CFO and ceftiofur -- CTF) and β-lactams -- thienamycin (imipenem -- IPM); aminoglycosides (streptomycin -- EST and gentamicin -- GEN); tetracyclin (tetracyclin -- TET); quinolones (ciprofloxacin -- CIP, enrofloxacin -- ENO and nalidixic acid -- NAL); nitrofuran (nitrofurantoin -- NIT); sulfonamide (cotrimoxazol -- SUT); anfenicol (chloramphenicol -- CLO). Strains were considered multiresistant when resistant to three or more antimicrobial categories.[@bib0385]

In search of resistance genes, we employed PCR techniques on the *E. coli* strains that presented antimicrobial resistant phenotypes. We searched for β-lactam resistance genes (*bla*~TEM~,[@bib0390] *bla*~SHV~,[@bib0390] *bla*~OXA~,[@bib0390] *bla*~CMY~,[@bib0395] and *bla*~CTX-M~[@bib0390]); and employed multiplex to access tetracycline (*tetA* and *tetB*),[@bib0400] aminoglycoside (*aadA*,[@bib0405] *aphA*,[@bib0410] and *strAB*[@bib0415]), sulfonamide (*sul1*,[@bib0415] *sul2*,[@bib0405] and *sul3*[@bib0420]), and quinolone resistance genes (*qnrA*,[@bib0425] *qnrD*,[@bib0430] *qnrB*,[@bib0425] *qnrS*,[@bib0435] *oqxAB*,[@bib0425] *aac(6)*′*-Ib-cr*,[@bib0440] *qnrC*,[@bib0425] and *qepA*[@bib0445]).

We used the PCR-*based replicon typing* (PBRT) technique on all *E. coli* isolates in search of characteristic markers for different plasmids of the Inc K/B, W, FIIA, FIA, FIB, Y, I1, F, X, HI1, N, H12 and L/M groups.[@bib0450]

The chi-square test was employed to compare the frequency of bacteria from pet shop, private residences and commercial breeders. *p*-values ≤0.05 were considered significant.

Results {#sec0015}
=======

*Salmonella* spp. was not isolated from the cloacal samples, on the other hand, *E. coli* was isolated in 10% (9/94) of the analyzed animals: one from a pet shop (1/8--13%), three from private residencies (3/28--11%), and five from commercial breeders (5/58--9%), with no statistical differences between bacterial isolation regarding the individual\'s origin.

Results of the virulence predictor genes and antimicrobial resistance profiles of all 27 analyzed strains are shown in [Table 1](#tbl0005){ref-type="table"}.Table 1*Escherichia coli* strains isolated from healthy cockatiels: origin, virulence genotype, antimicrobial phenotype/genotype and plasmids.Table 1AnimalOriginStrainVirulence genotypeResistance profilePhenotypeGenotypePlasmids1Pet shop1--EST*strAB*IncFIB2--CFE; EST; GEN*strAB*--3[a](#tblfn0005){ref-type="table-fn"}--AMO; CFE; CFO; EST; GEN; TET; ENO*strAB*IncFIB2Private residence1--AMP; CTF; EST; NAL*strAB*IncFIB; IncFIA2[a](#tblfn0005){ref-type="table-fn"}--AMP; EST; TET; CIP*strAB*IncFIB; IncFIA; IncY3[a](#tblfn0005){ref-type="table-fn"}--CTF; EST; CIP*strAB*IncFIB; IncFIA; IncY3Commercial breeding1[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO; EST; TET; CLO; ENO; CIP; NAL*bla*TEM*tetBstrAB*IncFIB2[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO; EST; TET; CLO; ENO; CIP; NAL*bla*TEM*tetBstrAB*IncI13[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO; EST; TET; CLO; ENO; NAL*bla*TEM*tetBstrAB*IncFIB4Commercial breeding1[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO; EST; TET; CLO; ENO; CIP; NAL; SUT*bla*TEM*tetBaadA*; *aphaA sul3*--2[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO;CFE; EST; TET; CLO; ENO; CIP; NAL; SUT*bla*TEM*tetBaadA*; *aphaA sul3*--3[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO;CFE; EST; TET; CLO; ENO; CIP; NAL; SUT*bla*TEM*tetBaadA*; *aphaA sul3*--5Commercial breeding1[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO; CFE; CTF; EST*bla*TEM*strAB*IncFIB2--AMP; AMO; CFE*bla*TEM*strAB*IncFIB3--AMP; AMO; EST*bla*TEMIncFIB6Commercial breeding1[a](#tblfn0005){ref-type="table-fn"}--AMO; CFE; EST*bla*TEM*strAB*IncFIB2[a](#tblfn0005){ref-type="table-fn"}--AMO; IPM; EST*bla*TEM*strAB*IncFIB3[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO; IPM; EST*bla*TEM*strAB*IncFIB7Commercial breeding1--AMP; AMO*bla*TEMIncFIB2--AMP; AMO; EST*bla*TEM*strAB*IncFIB3--AMP; AMO-IncFIB8Private residence1[a](#tblfn0005){ref-type="table-fn"}--AMP; AMO; EST; TET; SUT*tetBstrAB; aadA sul2*IncFIB; IncI12[a](#tblfn0005){ref-type="table-fn"}*ironN*, *ompT*, *hlyF* and *iss*AMP; AMO; CFE; TET; CLO; ENO; CIP; NAL; SUT*tetA sul1*IncI13[a](#tblfn0005){ref-type="table-fn"}*ironN*, *ompT*, *hlyF* and *iss*AMP; AMO; EST; TET; SUT*tetBstrAB; aadA sul2*IncFIB; IncI19Private residence1*iss*AMP; AMO; SUT*sul1*--2--AMP; AMO; SUT*sul1*--3--AMP; AMO; SUT*sul1*--[^1][^2]

With the exception of APEC-related genes, identified in two birds, we did not detect any other markers related to the remaining ExPEC (*papC*, *papEF*, *sfa*, *iucD*, *fyuA*, *cnf1*, *hly*, *cvaC*, *malX* and *iutA*) and diarrheagenic *E. coli* (*stx1*, *stx2*, *ST*, *LT*, *ial*, *aggR*, *eae* and *bfpA*).

None of the evaluated strains were positive for O157 and H7 antisera agglutination.

All strains were sensitive to nitrofurantoin. The highest resistance percentage was to β-lactams (93%). Amoxicillin and ampicillin were the antimicrobials with the highest number of resistant strains, 81% (22/27) and 78% (21/27), respectively, followed by streptomycin (74% -- 20/27) ([Fig. 1](#fig0005){ref-type="fig"}).Fig. 1Resistant *Escherichia coli* strains isolated from cockatiels according to the tested antimicrobial drugs. SUT, cotrimoxazol; NIT, nitrofurantoin; CLO, chloramphenicol; NAL, nalidixic acid; CIP, ciprofloxacin; ENO, enrofloxacin; GEN, gentamicin; EST, streptomycin; TET, tetracyclin; CFO, cefoxitin; CTF, ceftiofur; CFE, cephalexin; IPM, imipenem; AMP, ampicillin; AMO, amoxicillin.

The comparison between isolates' resistances and cockatiel origin showed that birds from pet shop and commercial breeders were predominantly resistant to penicillins, 89% and 100%, respectively, while private residences isolates were mostly resistant to aminoglycosides (100%) ([Fig. 2](#fig0010){ref-type="fig"}).Fig. 2*Escherichia coli* resistant strains according to cockatiel origin (pet shop, private residency, commercial breeder).

[Table 1](#tbl0005){ref-type="table"} shows that 30% (8/27) of the isolates were resistant to seven or more of the tested antibacterial drugs. Resistance to one or more antimicrobial categories was observed in 67% (18/27) of the strains, while 59% (16/27) of them were multiresistant ([Table 1](#tbl0005){ref-type="table"}). The most frequently observed multiresistance profile was a combination of penicillins, cephalosporins and aminoglycosides ([Table 1](#tbl0005){ref-type="table"}).

We observed that 96% (26/27) of the *E. coli* strains presented at least one of the surveyed resistance genes ([Table 1](#tbl0005){ref-type="table"}). In regards to antimicrobial categories, resistance genes of the aminoglycoside were detected in 77% (20/26) of the strains, 54% (14/26) of the penicillin, 35% (9/26) of the tetracyclin and sulfonamide, and 4% (1/26) of the quinolone isolates. Cephalosporin-related resistance genes were not observed.

The most frequently detected genes in the studied strains were *strAB* (17/26 -- 65%) and *bla*~TEM~ (14/26 -- 54%). The most varied resistance genotype profile was the *bla*~TEM~ *tetB aad aphaA sul3*, present in three strains isolated from one single animal that belonged to a commercial breeder ([Table 1](#tbl0005){ref-type="table"}).

The PBRT technique allowed us to identify and classify plasmids in 74% (20/27) of the *E. coli* isolates. The IncFIB was the most recurrent Inc, present in 67% (18/27) of the strains, followed by IncI1 (4/27 -- 15%), IncFIA (3/27 -- 11%) and IncY (2/27 -- 7%). Five samples presented more than one plasmid Inc group.

Discussion {#sec0020}
==========

Data on *Salmonella* spp. epidemiology in wild and domestic animals are very important in the detection of these agents' potential reservoirs.[@bib0455] We did not isolate bacteria from this genus in this study -- a suggestion that the studied cockatiels did not present any risks of transmitting such pathogens to humans or animals, as previously observed in a study performed in psittacines.[@bib0455]

*Salmonella* spp. can be considered one of the most important pathogen in commercial poultry industry, and the presence of these microorganisms is associated with intensive breeding. At the same time, previous studies show a low prevalence of *Salmonella* spp. in wild birds, and most of the reports are related to the illegal wildlife traded.[@bib0285], [@bib0395] In this study, *Salmonella* spp. was not detected in birds from pet shop, private residences or commercial breeders. However, the zoonotic importance of this agent justifies its monitoring in aviary species.

One of the first survey studies, performed in 125 psittacines of 12 different species, detected *E. coli* in 14% of the birds[@bib0460] -- results similar to our findings. However, later studies mentioned higher isolation percentages, up to 48%.[@bib0455]

In this research, we did not observe any differences in the isolation of *E. coli* regards to origin (private residencies, pet shops or commercial breeders), concluding that the people handling these birds were exposed to similar risks, regardless of the birds' origin.

Herein we tested avian virulence predicting genes in 27 strains: three (11%) isolates from cockatiels living in private residencies presented the *iss* gene, two of them with *iroN*, *ompT* and *hlyF* genes, all characteristic of the APEC subgroup. Therefore, although these birds were apparently healthy, they carried potentially pathogenic strains.

Studies have shown the existence of genotypic and phenotypic similarities between avian extraintestinal *E. coli* strains (APEC), urinary infections (UPEC),[@bib0270], [@bib0465] and neonatal meningitis.[@bib0265] Such results reinforce the hypothesis that birds may be reservoirs of *E. coli* pathogenic to mammals.[@bib0265], [@bib0270], [@bib0465] Thus, it is possible to suggest the potential transmission risk of these zoonotic diseases to the owners and caretakers of the analyzed birds.

Even though other researchers have detected the *eae*[@bib0470] and *stx2*[@bib0475] genes in psittacine fecal samples, suggesting that these birds could be reservoirs of EPEC and STEC to humans, we did not observe virulence genes for the diarrheagenic *E. coli* in this survey.

All strains evaluated in this study were resistant to at least one of the tested antimicrobials categories, except for nitrofurantoin, similarly to what was observed in a study performed in psittacines from a conservationist breeder.[@bib0455] Our results showed that 30% of the strains were resistant to seven or more antimicrobial drugs and 59% were multiresistant. *E. coli* resistance to two or more antimicrobial groups is currently considered a common finding, both in human and veterinary medicine.[@bib0385], [@bib0415] This represents a great impact over viable therapeutic options and potential dispersion of these pathogens in the community, one of the most relevant global public health issues.[@bib0385]

The highest resistance percentage was related to β-lactams (93%), of which 89% of the strains were resistant to penicillin. Several authors have also observed a high percentage of penicillin resistance, up to 100%, in psittacines and passeriforms.[@bib0295] We verified that 52% of the strains presented the *bla*~TEM~,[@bib0390] suggests that up to 90% of *E. coli* ampicillin resistance is due to TEM-1 and TEM-2 enzymes coded by the *bla*~TEM~ gene.

The isolates presented increased resistance to aminoglycosides (74%), particularly to streptomycin (67%). Similar resistance levels have been observed in wild birds (63%).[@bib0480] We detected that 85% of the streptomycin-resistant strains presented the *strAB* gene, justifying the high resistance levels noticed for this drug.

Similarly, the *tetB* gene was detected in 80% of the tetracycline-resistant strains. Researchers have obtained high frequencies of tetracycline resistance in *E. coli* strains of animal origin and *tetB* gene has also been the most commonly reported gene in human isolates.[@bib0485]

In a study performed in Brazil, *E. coli* strains isolated from wild frigates presented low ciprofloxacin and enrofloxacin resistance indexes.[@bib0305] However, the strains isolated in our study presented 41% resistance to quinolones. This high resistance percentage may be related to selective pressure, a result of veterinary therapies established with no laboratory support and empirical treatments with no veterinary supervision. This factor is especially relevant when one considers the commercial formulation of this antimicrobial category, which is focused on the avian pet market and commercialized without any governmental control.

In this study, 33% of the sulfonamide-resistant *E. coli* strains presented the *sul1*, *sul2* and *sul3* genes, frequently reported in resistant isolates of human origin.[@bib0490]

Increased Gram-negative resistance is mainly attributed to mobile genes present in plasmids, which may be disseminated within bacterial populations.[@bib0450], [@bib0495] Air travels, human migrations and animal transit allow rapid transportation of bacterial plasmids among countries and continents. Four plasmids were detected in this study: IncFIB, IncFIA, IncY and IncI1. The FIB group was observed in strains that presented phenotypical resistance to β-lactams, aminoglycosides and quinolones. Our findings are in accordance with the available bibliography, which states that plasmids of the IncF family are broadly distributed in *E. coli* commensals, but carry quinolone and aminoglycoside resistance genes and ESBL encoding genes.[@bib0450]

Strains presenting plasmid IncI1 were phenotypically resistant to penicillins, and one of them to cephalexin. Plasmids IncI1 and IncY are also related to the distribution of ESBL acquisition genes and quinolone resistance.[@bib0450] Furthermore, IncI1 is characterized by encoding the type IV *pili*, a virulence factor that contributes to bacterial adhesion and invasion. This virulence characteristic has been related to Shiga toxin producing *E. coli* (STEC)[@bib0450] and to the highly pathogenic APEC strains,[@bib0500] which may contribute to the pathogenic potential presented by the APEC strains with virulence markers detected in this study.

We observed high antimicrobial resistance in the strains isolated from healthy captive cockatiels, including multiresistance, as well, we detected the presence of plasmids and genes related to resistance phenotype. *E. coli* strains with pathogenic potential presented important APEC virulence factors. From a zoonotic point of view it is important to highlight the relevance of maintaining pets and disseminating these bacteria to other animals, to humans, and the environment.
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[^1]: AMO, amoxicillin; AMP, ampicillin; CFE, cephalexin; CFO, cefoxitin; CTF, ceftiofur; IPM, imipenem; EST, streptomycin; GEN, gentamicin; TET, tetracyclin; CIP, ciprofloxacin; ENO, enrofloxacin; NAL, nalidixic acid; SUT, cotrimoxazol; CLO, chloramphenicol.

[^2]: Multiresistant strains.
